About Procell Biologics
Procell Biologics is a Healthcare company based in Hyderabad (India) founded in 2021. It develops biosimilars for metabolic disorders, inflammatory diseases, and cancer treatments. It operates on a B2B and Manufacturing model. The company has 52 employees. Procell Biologics offers products and services including Biosimilars and Biotherapeutic Research. Its focus areas include Biopharmaceuticals, Research Services, Biotherapeutics Development and Biosimilars. Its legal entity in India is Procell Biologics Private Limited (U24290TG2021PTC150610).
Company details
Procell Biologics, established in 2021, focuses on developing and manufacturing biosimilars and biotherapeutics for metabolic disorders, inflammatory diseases, and cancer. The company operates from Hyderabad, India, serving domestic and international markets through research and production capabilities. It plans to expand into CDMO services by 2024, providing cost-efficient healthcare solutions while building a repository of expertise in biologics.
- Headquarters Hyderabad, India
- Employees 52
- SectorsHealthcare
- Email••••••••
- Website procellbiologics.com
- Social LinkedIn
- Legal Name Procell Biologics Private Limited
- Date of Incorporation 14 Apr, 2021
- Jurisdiction Medchal Malkajgiri, Telangana, India
- Annual Revenue₹14,740
FY 2025 · -99% YoY
- Net Loss-₹13.01 Cr
FY 2025 · -882546% margin
- EBITDA-₹10.65 Cr
FY 2025 · -722661% margin
- Employee Count52
Associated legal entities of Procell Biologics
Procell Biologics operates through Procell Biologics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Procell Biologics Private Limited CIN U24290TG2021PTC150610 | Active | 14 Apr 2021 | Medchal, Telangana | ₹0.0 Cr | 52 | 6 | View details |
Products & Services of Procell Biologics
Procell Biologics offers a comprehensive portfolio of products and services, including Biosimilars and Biotherapeutic Research.
Treatments targeting metabolic disorders, inflammatory diseases, and cancer.
Development of biotherapeutics for healthcare applications.
Board of directors of Procell Biologics Private Limited (Procell Biologics)
Procell Biologics Private Limited is the primary company behind Procell Biologics. The board of Procell Biologics Private Limited currently have 5 directors; the longest-serving is Srinivasa Chowdary Akkina, appointed in 2021. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Srinivasa Chowdary Akkina DIN 02658262 | Director | 14 Apr 2021 | 5 yrs 6 mo | Procell Biologics Private Limited |
| Srinivas Suveerji Cherukuri DIN 07248538 | Director | 14 Apr 2021 | 5 yrs 6 mo | Procell Biologics Private Limited |
| Muni Koteswara Rao Akkina DIN 02576546 | Director | 14 Apr 2021 | 5 yrs 6 mo | Procell Biologics Private Limited |
| Surya Prabhavathi Akkina DIN 02580087 | Director | 14 Apr 2021 | 5 yrs 6 mo | Procell Biologics Private Limited |
| Venkata Krishnaji Cherukuri DIN 02576559 | Director | 14 Apr 2021 | 5 yrs 6 mo | Procell Biologics Private Limited |
Financials of Procell Biologics
Figures of Procell Biologics Private Limited, the primary company behind Procell Biologics, for FY 2025. Revenue was ₹14,740 (-99% year on year). Net loss was -₹13.01 Cr (-882546% margin). EBITDA was -₹10.65 Cr (-722661% margin).
- ₹14,740Revenue · FY 2025 · -99% YoY
- -₹13.01 CrNet loss · -882546% margin
- -₹10.65 CrEBITDA · -722661% margin
- ₹10.37 CrPaid-up capital
- 52Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Procell Biologics Private Limited are on its company page.
Detailed financial statements for Procell Biologics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Procell Biologics (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Procell Biologics
Procell Biologics was founded in 2021.
Procell Biologics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Procell Biologics has 52 employees.
The primary company behind Procell Biologics, Procell Biologics Private Limited, reported revenue of ₹14,740 for FY 2025, down 99% year on year.
Procell Biologics, established in 2021, focuses on developing and manufacturing biosimilars and biotherapeutics for metabolic disorders, inflammatory diseases, and cancer. The company operates from Hyderabad, India, serving domestic and international markets through research and production capabilities. It plans to expand into CDMO services by 2024, providing cost-efficient healthcare solutions while building a repository of expertise in biologics.
Procell Biologics offers Biosimilars and Biotherapeutic Research.
Procell Biologics operates through Procell Biologics Private Limited.
The legal entities of Procell Biologics currently have 6 directors, including Srinivasa Chowdary Akkina, Srinivas Suveerji Cherukuri, Megha Aggarwal and others.